Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to boost HIV testing and care for teen girls in zambia

NCT ID NCT03995953

Prevention Sponsor: RTI International Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a package of services to help adolescent girls and young women in Zambia get regular HIV testing, prevention, and treatment. The program included education sessions, youth clubs, and special clinics offering integrated care. Over 2,000 girls aged 10–20 took part, but the COVID-19 pandemic prevented collection of some key follow-up data.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SHIELD intervention (education, youth clubs, caregiver support) and integrated wellness care clinics
What this could lead to
If successful, this approach could provide a practical model to improve HIV testing, prevention, and treatment among adolescent girls in high-risk settings.
What could go wrong
The trial was completed but key data on retention and viral load were not collected due to COVID-19, limiting conclusions. The interventions are behavioral and depend on local implementation, so results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,150 people

The number who actually took part.

Started

May 2021

Finished

Mar 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 24 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: HIV negative or unknown cohort * Female * 10 to 20 years of age * self-report HIV status as negative or unknown (no HIV testing within the past 6 months * not pregnant, does not suspect pregnancy, and does not express a desire to become pregnant over the next 18 months * is willing to sign a release for medical records (to obtain clinic data on service use) * plans to reside in the current location for the next 18 months * has not been part of the other planned formative research activities HIV positive cohort * Female * 16 to 24 years of age * diagnosed with HIV within the past 3 years or newly diagnosed at the time of the study * not pregnant, does not suspect pregnancy, and does not express a desire to become pregnant over the next 18 months * is willing to sign a release for medical records (to obtain clinic data on service use) * plans to reside in the current location for the next 18 months * has not been part of the other planned formative research activities Exclusion Criteria: * pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

  • Population Council

    Lusaka, Zambia

More trials for these conditions

Other studies related to the condition(s) this trial covers.